BRIEF-Biogen says Nature publishes results from phase 1B study of Aducanumab
August 31, 2016 at 13:21 PM EDT
* Nature publishes results from pre-clinical research and phase 1B study of Biogen's investigational Alzheimer's disease treatment Aducanumab
